Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center

Cancer

Volumn 124, Issue 21, 2018, Pages 4137-4144

  Kim, Karen E ^a   Randal, Fornessa ^a   Johnson, Matt ^a   Quinn, Michael ^a   Maene, Chieko ^a   Hoover, Sonja ^b   Richmond Reese, Valerie ^c   K L Tangka, Florence ^c   Joseph, Djenaba A ^c   Subramanian, Sujha ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b RTI INTERNATIONAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cancer screening; Chicago; cost effectiveness; patient navigation

Indexed keywords

ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; HEALTH CARE COST; HUMAN; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; RISK ASSESSMENT; ADULT; AGED; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; FEMALE; ILLINOIS; MALE; MASS SCREENING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT PARTICIPATION; PROCEDURES; UNIVERSITY HOSPITAL;

ADULT; AGED; CHICAGO; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT NAVIGATION; PATIENT PARTICIPATION;

EID: 85055553816     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31690     Document Type: Article

References (32)

1. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564-2575.
2. US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-Based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2017. https://www.cdc.gov/uscs. Accessed January 4, 2018.
3. White A, Thompson TD, White MC, et al. Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201-206.
4. List DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med. 2014;46:228-236.
5. Gupta S, Tong L, Allison JE, et al. Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy. Cancer Epidemiol Biomarkers Prev. 2009;18:2373-2379.
6. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:1611-1621.
7. Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf L. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc. 2008;100:278-284.
8. Percac-Lima S, Grant RW, Green AR, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized controlled trial. J Gen Intern Med. 2009;24:211-217.
9. Ma GX, Shive S, Tan Y, et al. Community-based colorectal cancer intervention in underserved Korean Americans. Cancer Epidemiol. 2009;33:381-386.
10. Johnson DA, Barkun AN, Cohen LB, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2014;109:1528-1545.
11. Jandorf L, Stossel LM, Cooperman JL, et al. Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities. Cancer. 2013;119:612-620.
12. Ladabaum U, Mannalithara A, Jandorf L, Itzkowitz SH. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer. 2015;121:1088-1097.
13. Lairson DR, Dicarlo M, Deshmuk AA, et al. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care. Cancer. 2014;120:1042-1049.
14. Elkin EB, Shapiro E, Snow JG, Zauber AG, Krauskopf MS. The economic impact of a patient navigator program to increase screening colonoscopy. Cancer. 2012;118:5982-5988.
15. Naylor K, Fritz C, Polite B, Kim K. Evaluating screening colonoscopy quality in an uninsured urban population following patient navigation. Prev Med Rep. 2017;5:194-199.
16. Fritz C, Naylor K, Kim K. Knowledge of polyp history and recommended follow-up among a predominately African American patient population and the impact of patient navigation. J Racial Ethn Health Disparities. 2016;3:403-412.
17. Lebwohl B, Neugut AI, Stavsky E, et al. Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol. 2011;45:e47-e53.
18. Subramanian S, Tangka FK, Hoover S, et al. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 2013;119(suppl 15):2855-2862.
19. Subramanian S, Tangka FK, Hoover S, DeGroff A, Royalty J, Seeff LC. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of 5 programs. Eval Program Plann. 2011;34:147-153.
20. Subramanian S, Tangka FKL, Hoover S, Royalty J, DeGroff A, Joseph D. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: comparisons of colonoscopy and FOBT/FIT based screening. Eval Program Plann. 2017;62:73-80.
21. Tangka FK, Subramanian S, Bapat B, et al. Cost of starting colorectal cancer screening programs: results from 5 federally funded demonstration programs [serial online]. Prev Chronic Dis. 2008;5:A47.
22. Tangka FK, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer. 2013;119(suppl 15):2863-2869.
23. Tangka FKL, Subramanian S, Hoover S, et al. Costs of promoting cancer screening: evidence from CDC's Colorectal Cancer Control Program (CRCCP). Eval Program Plann. 2017;62:67-72.
24. DeGroff A, Schroy PC 3rd, Morrissey KG, et al. Patient navigation for colonoscopy completion: results of an RCT. Am J Prev Med. 2017;53:363-372.
25. Reuland DS, Brenner AT, Hoffman R, et al. Effect of combined patient decision aid and patient navigation vs usual care for colorectal cancer screening in a vulnerable patient population: a randomized clinical trial. JAMA Intern Med. 2017;177:967-974.
26. Chen LA, Santos S, Jandorf L, et al. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol. 2008;6:443-450.
27. Jean-Pierre P, Hendren S, Fiscella K, et al. Understanding the processes of patient navigation to reduce disparities in cancer care: perspectives of trained navigators from the field. J Cancer Educ. 2011;26:111-120.
28. Berg BP, Murr M, Chermak D, et al. Estimating the cost of no-shows and evaluating the effects of mitigation strategies. Med Decis Making. 2013;33:976-985.
29. Tibble JA, Forgacs I, Bjarnason I, Przemioslo R. The effects of a preassessment clinic on nonattendance rates for day-case colonoscopy. Endoscopy. 2000;32:963-965.
30. Adams LA, Pawlik J, Forbes GM. Nonattendance at outpatient endoscopy. Endoscopy. 2004;36:402-404.
31. Shires DA, Divine G, Schum M, et al. Colorectal cancer screening use among insured primary care patients. Am J Manag Care. 2011;17:480-488.
32. Subramanian S, Ekwueme DU, Gardner JG, Trogdon J. Developing and testing a cost-assessment tool for cancer screening programs. Am J Prev Med. 2009;37:242-247.